SCHEMBL6231872

SCHEMBL6231872

Brc1ccc(CC=CCc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.71
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
ARG2 P78540 1/20 0.48
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
TOP1 P11387 1/20 0.44
MAPK1 P28482 1/20 0.44
GPR52 Q9Y2T5 1/20 0.43
IDO1 P14902 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MME P08473 2/20 0.40
TRPA1 O75762 1/20 0.40
TSHR P16473 1/20 0.40
PDPK1 O15530 1/20 0.40
HTR2A P28223 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1524697 0.84 MAOB (1.00) MAOBCA1CA2ARG2ALDH1A1
SCHEMBL155055 0.84 MAOB (1.00) MAOBCA1CA2ARG2ALDH1A1
SCHEMBL155054 0.84 MAOB (1.00) MAOBCA1CA2ARG2ALDH1A1
SCHEMBL15527347 0.83 MAOB (0.48) MAOBALDH1A1TDP1GPR52IDO1
SCHEMBL3847991 0.83 MAOB (0.48) MAOBALDH1A1TDP1GPR52IDO1
SCHEMBL28760384 0.79 MAOB (0.42) MAOBGPR52IDO1HTR2ATAAR1
SCHEMBL6667272 0.78 MAOB (0.48) MAOBCA1CA2ARG2ALDH1A1
SCHEMBL28743524 0.78 IDO1 (0.44) MAOBIDO1HTR2ATAAR1
SCHEMBL3293785 0.78 MAOB (0.75) MAOBCA1CA2ARG2ALDH1A1
SCHEMBL28348050 0.78 MAOB (0.75) MAOBCA1CA2ARG2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1529030-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID Prestwick Pharmaceuticals, Inc. (US) 2005-05-11 EP disclosed
WO-2004016580-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID PRESTWICK PHARMACEUTICALS, INC. (US) 2004-02-26 WO disclosed